Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 8-methoxy-6-nitrophenanthro(3,4-d)-1,3-dioxole-5-carboxylic Acid
2. Aristolochic Acid
3. Aristolochic Acid A
4. Aristolochic Acid I
5. Aristolochic Acid I, Sodium Salt
6. Tardolyt
1. 10190-99-5
2. Sodium Aristolate 1
3. Sodium Aristolochate-i
4. Aristolochic Acid Sodium Salt
5. Ktm3d3h78e
6. Aristolochic Acid, Sodium Salt
7. Aristolochic Acid, Sodium Salt (77% Aa I, 21% Aa Ii)
8. Sodium;8-methoxy-6-nitronaphtho[2,1-g][1,3]benzodioxole-5-carboxylate
9. Phenanthro(3,4-d)-1,3-dioxole-5-carboxylic Acid, 8-methoxy-6-nitro-, Sodium Salt
10. Ccris 6498
11. Einecs 233-463-4
12. Unii-ktm3d3h78e
13. Mfcd00210760
14. Dsstox_cid_99
15. Sodium 8-methoxy-6-nitrophenanthro(3,4-d)-1,3-dioxole-5-carboxylate
16. Dsstox_rid_75366
17. Dsstox_gsid_20099
18. Chembl3187459
19. Dtxsid3020099
20. Niosh/sf8281000
21. Schembl15537024
22. Aristolochic Acid I, Sodium Salt
23. Tox21_200026
24. Ncgc00257580-01
25. Cas-10190-99-5
26. Ft-0645091
27. Sf82810000
28. Aristolochic Acid I Sodium Salt, Powder, >=97%
29. Aristolochic Acid, Sodium Salt [who-dd]
30. Q27282434
31. Aristolochic Acid Sodium Salt (i And Ii) For Biochemistry
32. Sodium 8-methoxy-6-nitrophenanthro[3,4-d][1,3]dioxole-5-carboxylate
33. 8-methoxy-6-nitrophenanthro(3,4-d)-1,3-dioxole-5-carboxylic Acid Sodium Salt
34. Aristolocholic Acid For System Suitability, European Pharmacopoeia (ep) Reference Standard
35. Phenanthro[3,4-d]-1,3-dioxole-5-carboxylicacid,8-methoxy-6-nitro-,sodium Salt(1:1)
36. 52232-70-9
| Molecular Weight | 363.25 g/mol |
|---|---|
| Molecular Formula | C17H10NNaO7 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 1 |
| Exact Mass | 363.03549594 g/mol |
| Monoisotopic Mass | 363.03549594 g/mol |
| Topological Polar Surface Area | 114 Ų |
| Heavy Atom Count | 26 |
| Formal Charge | 0 |
| Complexity | 544 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Mutagens
Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)
Carcinogens
Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)
ABOUT THIS PAGE
10
PharmaCompass offers a list of Sodium Aristolate 1 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sodium Aristolate 1 manufacturer or Sodium Aristolate 1 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sodium Aristolate 1 manufacturer or Sodium Aristolate 1 supplier.
PharmaCompass also assists you with knowing the Sodium Aristolate 1 API Price utilized in the formulation of products. Sodium Aristolate 1 API Price is not always fixed or binding as the Sodium Aristolate 1 Price is obtained through a variety of data sources. The Sodium Aristolate 1 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Sodium Aristolate 1 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sodium Aristolate 1, including repackagers and relabelers. The FDA regulates Sodium Aristolate 1 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sodium Aristolate 1 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Sodium Aristolate 1 supplier is an individual or a company that provides Sodium Aristolate 1 active pharmaceutical ingredient (API) or Sodium Aristolate 1 finished formulations upon request. The Sodium Aristolate 1 suppliers may include Sodium Aristolate 1 API manufacturers, exporters, distributors and traders.
Sodium Aristolate 1 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sodium Aristolate 1 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sodium Aristolate 1 GMP manufacturer or Sodium Aristolate 1 GMP API supplier for your needs.
A Sodium Aristolate 1 CoA (Certificate of Analysis) is a formal document that attests to Sodium Aristolate 1's compliance with Sodium Aristolate 1 specifications and serves as a tool for batch-level quality control.
Sodium Aristolate 1 CoA mostly includes findings from lab analyses of a specific batch. For each Sodium Aristolate 1 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sodium Aristolate 1 may be tested according to a variety of international standards, such as European Pharmacopoeia (Sodium Aristolate 1 EP), Sodium Aristolate 1 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sodium Aristolate 1 USP).
